£198k
−30%vs Mar 2024Active09492957Private limited companyDorking
LIMEWAY PHARMA DESIGN LIMITED
Significant control: Adrian Davis (25–50%), Sarah Judith Davis (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Limeway Pharma Design Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
LIMEWAY PHARMA DESIGN LIMITED is an active private limited company (company number 09492957) incorporated on 17 March 2015, registered in Dorking. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of £198k and cash of £144k, with 0 employees on average. Net assets fell 30% on the prior period (£282k).
Peer position · net assets
By net assets it sits in the top quarter of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
02
Ownership and control
- Dr Adrian Davis
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mrs Sarah Judith Davis
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 17 March 201511 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 31 March 2027in 159 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£144k
−34%vs Mar 2024Not reported
0
vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £198k | £144k | £7,989 | — | — | — | 0 |
| 31 March 2024 | £282k | £217k | £51 | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £197,745 at 31 March 2025
- Net assets down 25% or more on the prior period-29.9% vs prior period
- Cash at bank of £50,000 or moreCash £144,159
- Incorporated five or more years agoIncorporated 17 March 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 159 days
- Next accounts duein 69 days
- Accounts period endNet assets £198k · small accounts
- Accounts period endNet assets £282k · small accounts
- Incorporated
08
Similar companies in Surrey
- TRUSPINE TECHNOLOGIES INTERNATIONAL LIMITEDGatwick · inc. Dec 2014
- HEATH RESEARCH LTDFarnham · inc. Jun 2015
- TSP ADVANCED TECHNOLOGIES PLCGatwick · inc. Dec 2014
- SENTURION PHARMA LTDBurgess Hill · inc. Nov 2014
- GLOBAL EYE TRIALS LTDHorsham · inc. Aug 2015
- NATURE METRICS LTDGuildford · inc. Oct 2014
All companies incorporated on 17 March 2015 · in Mar 2015.
09
Reminders for LIMEWAY PHARMA DESIGN LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.